InterAx partners with Lundbeck to identify better pharmaceutical compounds

InterAx Biotech AG, a spin-off of the Paul Scherrer Institute PSI and ETH Zurich, based at PARK INNOVAARE, is building a proprietary systems biology platform...

More details More details

Villigen – Boston – Villigen: Successful Business Trip for InterAx Biotech AG

InterAx Biotech AG participated in a “business boosting” week in Boston, USA, in June, 2016. As part of venturelab’s international program, 10 high...

More details

InterAx raises CHF 3 Mio for the commercialization of its systems biology platform

InterAx Biotech AG is a spin off from the ETH Zürich and Paul Scherrer Institute (PSI). The company assists GPCR drug candidate design and selection by...

More details

A perfect site for biotech and pharma companies!

Drug discovery has come a long way from crude extracts to pure chemicals, from guess work to a structural and targeted approach to finding new and better...

More details

Life Science basic research on the top level

The Paul Scherrer Institute (PSI) is Switzerland’s biggest research institute for natural and engineering sciences. It hosts most of the country’s...

More details
Subscribe to Biotechnology